| Citation: |
JIANG Mingting, HUANG Jin, ZHENG Shuping. Effects of Pin1 on Proliferation and Apoptosis of HepG2 Cells Under Endoplasmic Reticulum Stress[J]. Cancer Research on Prevention and Treatment, 2022, 49(6): 575-580. DOI: 10.3971/j.issn.1000-8578.2022.21.1097
|
To investigate the expression of Pin1 protein in HepG2 cells under endoplasmic reticulum stress (ERS) and its effect on cell proliferation and apoptosis.
The THLE3 cells were treated with tunicamycin (TM) (TM group) or DMSO (DMSO group) for 48h. The HepG2 cells were treated with TM (TM group), ATRA(ATRA group), TM+ATRA (TM+ATRA group) or DMSO (DMSO group) for 48h. The protein levels of Bip and Pin1 were detected by Western blot, cell proliferation was detected by CCK-8 assay, and cell apoptosis was detected by flow cytometry.
The expression of Bip both increased in THLE3 and HepG2 cells treated with TM, indicated that TM effectively induced ERS in cells. Compared with the DMSO group, the protein level of Pin1 in THLE3 cells in TM group was decreased with the increasing of TM concentration (P < 0.001). In TM+ATRA group, with the increasing of TM concentration, the expression of Pin1 was decreased in HepG2 cells (P < 0.01). The inhibitory rates was (29.33±4.73)% in HepG2 cells in TM group, significantly lower than (60.33±2.08)% in THLE3 cells in TM group (P < 0.001). In TM+ATRA group, the growth inhibition rates was increased to (60.33±6.03)% in HepG2 cells. The apoptosis rate of THLE3 cells in TM group was (22.25±0.78)%, significantly higher than (3.57±0.31)% in DMSO group (P < 0.01). The apoptosis rates of HepG2 cells in ATRA group and TM+ATRA group were significantly higher than that in the DMSO group ((10.03±0.49)% vs. (5.10±1.00)%, P < 0.05 and (23.70±0.75)% vs. (5.10±1.00)%, P < 0.01).
HepG2 cells resist ERS-induced apoptosis by maintaining Pin1 protein level. Reducing the protein level of Pin1 can significantly inhibit the cell proliferation and induce apoptosis.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Almanza A, Carlesso A, Chintha C, et al. Endoplasmic reticulum stress signalling- from basic mechanisms to clinical applications[J]. FEBS J, 2019, 286(2): 241-278. doi: 10.1111/febs.14608
|
| [2] |
Hu H, Tian M, Ding C, et al. The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection[J]. Front Immunol, 2019, 9: 3083. doi: 10.3389/fimmu.2018.03083
|
| [3] |
Chipurupalli S, Kannan E, Tergaonkar V, et al. Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer[J]. Int J Mol Sci, 2019, 20(3): 749. doi: 10.3390/ijms20030749
|
| [4] |
Oakes SA. Endoplasmic Reticulum Stress Signaling in Cancer Cells[J]. Am J Pathol, 2020, 190(5): 934-946. doi: 10.1016/j.ajpath.2020.01.010
|
| [5] |
Sisinni L, Pietrafesa M, Lepore S, et al. Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance[J]. Int J Mol Sci, 2019, 20(4): 857. doi: 10.3390/ijms20040857
|
| [6] |
Siwecka N, Rozpedek W, Pytel D, et al. Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis[J]. Int J Mol Sci, 2019, 20(18): 4354. doi: 10.3390/ijms20184354
|
| [7] |
Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2021, 7(1): 7. doi: 10.1038/s41572-021-00245-6
|
| [8] |
Villanueva A. Hepatocellular Carcinoma[J]. N Engl J Med, 2019, 380(15): 1450-1462. doi: 10.1056/NEJMra1713263
|
| [9] |
Fabregat I. Dysregulation of apoptosis in hepatocellular carcinoma cells[J]. World J Gastroenterol, 2009, 15(5): 513-520. doi: 10.3748/wjg.15.513
|
| [10] |
Wu XZ. New strategy of antiangiogenic therapy for hepatocellular carcinoma[J]. Neoplasma, 2008, 55(6): 472-481.
|
| [11] |
Yu JH, Im CY, Min SH. Function of PIN1 in Cancer Development and Its Inhibitors as Cancer Therapeutics[J]. Front Cell Dev Biol, 2020, 8: 120. doi: 10.3389/fcell.2020.00120
|
| [12] |
Pu W, Zheng Y, Peng Y. Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance[J]. Front Cell Dev Biol, 2020, 8: 168. doi: 10.3389/fcell.2020.00168
|
| [13] |
Nakatsu Y, Matsunaga Y, Ueda K, et al. Development of Pin1 Inhibitors and their Potential as Therapeutic Agents[J]. Curr Med Chem, 2020, 27(20): 3314-3329. doi: 10.2174/0929867325666181105120911
|
| [14] |
Jeong K, Kim SJ, Oh Y, et al. p53 negatively regulates Pin1 expression under ER stress[J]. Biochem Biophys Res Commun, 2014, 454(4): 518-523. doi: 10.1016/j.bbrc.2014.10.101
|
| [15] |
Bae JS, Noh SJ, Kim KM, et al. PIN1 in hepatocellular carcinoma is associated with TP53 gene status[J]. Oncol Rep, 2016, 36(4): 2405-2411. doi: 10.3892/or.2016.5001
|
| [16] |
Lukas J, Pospech J, Oppermann C, et al. Role of endoplasmic reticulum stress and protein misfolding in disorders of the liver and pancreas[J]. Adv Med Sci, 2019, 64(2): 315-323. doi: 10.1016/j.advms.2019.03.004
|
| [17] |
Zhang LJ, Chen S, Wu P, et al. Inhibition of MEK blocks GRP78 up-regulation and enhances apoptosis induced by ER stress in gastric cancer cells[J]. Cancer Lett, 2009, 274(1): 40-46. doi: 10.1016/j.canlet.2008.08.030
|
| [18] |
Rampone B, Schiavone B, Martino A, et al. Current management strategy of hepatocellular carcinoma[J]. World J Gastroenterol, 2009, 15(26): 3210-3216. doi: 10.3748/wjg.15.3210
|
| [19] |
Bukowski K, Kciuk M, Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy[J]. Int J Mol Sci, 2020, 21(9): 3233. doi: 10.3390/ijms21093233
|
Figures(6)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: